Tulex Pharmaceutical
  • Home
  • Leadership
  • Partnerships
  • Pipeline
  • R & D
    • Specialized drug delivery technologies
    • Complex oral dosage forms development
  • Facilities
  • Careers
  • Contact Us

Our Facility

Fully Integrated c-GMP Facility is an FDA-inspected site and complies fully with cGMP, OHSA, DEA (CIII-V), EPA standards (methanol, ethanol, isopropyl alcohol, acetone), operating from 35,000 sq. ft. state-of-the art R&D and commercial manufacturing facility capable of developing complex oral dosage forms with solvent processing features including:
  • Granulation, tableting and coating
  • Fluid bed process (top, bottom spray and rotor)
  • Extrusion/spheronization
  • Nano wet milling

Complete Analytical Capability from pre-formulation R&D development to QC testing
  • Raw material/drug product testing, method development/validation, elemental impurity testing, reverse engineering, extractable / leachable 

​High Quality & Diverse Instrumentation
  • UPLC/HPLC, USP dissolution tester, LC-MS, GC-MS, HS-GC, ICP-MS, Malvern Mastersizer 3000 (dry & wet), Dynamic Light Scattering nano particle size analyzer

Facility

cGmp Facility

Utilizing the same type of equipment train from pilot to submission/commercial batches
ExtruderSpheronizer
Rotor Processor
Fluid Bed Processor
Tablet Coater
Fluid Bed Processor
Fluid Bed Dryer
Picture
High Shear Granulator
Picture
Wurster Processor
© 2020 Tulex Pharmaceutical
  • Home
  • Leadership
  • Partnerships
  • Pipeline
  • R & D
    • Specialized drug delivery technologies
    • Complex oral dosage forms development
  • Facilities
  • Careers
  • Contact Us